Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-6
Closed -$1.99K 309
2024
Q4
$1.99K Sell
6
-7
-54% -$2.37K ﹤0.01% 228
2024
Q3
$4.34K Hold
13
﹤0.01% 213
2024
Q2
$5.35K Hold
13
0.01% 200
2024
Q1
$5.25K Hold
13
0.01% 193
2023
Q4
$3.98K Buy
+13
New +$3.51K ﹤0.01% 211

Other funds holding MEDP

Fairman Group's MEDP Position: Q1 2025 in Review

Fairman Group sold out of Medpace (MEDP) in Q1 2025, closing a stake of 6 shares — an estimated $1.99K sold.

Fairman Group first reported a position in MEDP in Q4 2023 and held it in 5 quarters. The position peaked at $5.35K in Q2 2024. 586 funds tracked by Wall St. Rank hold MEDP as of Q1 2025.

  • Fairman Group reported no remaining Medpace position as of Q1 2025 after selling out during the quarter.
  • Fairman Group sold 6 Medpace shares in Q1 2025, an estimated $1.99K.
  • Fairman Group first reported a position in Medpace in Q4 2023 and held it in 5 quarters.
  • Fairman Group's Medpace position peaked at $5.35K in Q2 2024.
  • 586 funds tracked by Wall St. Rank held Medpace as of Q1 2025.

Based on Fairman Group's 13F filing for Q1 2025, filed 7 May 2025.